Form 20-F/A BioNTech SE For: Dec 31
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260730/AQVZC22CZ22FB2Z2222B22ZNGDQDZZ229Y82
Filed on: July 30, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Reiterates Buy Rating on BioNTech (BNTX) Following Lung Cancer Updates
- Bimergen Energy Opens New Federal Market Channel for Energy Storage
- BioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patie
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
